Xiamen LP Pharmaceutical Co., Ltd.
PrivateLast Round
Series C
Aug 19, 2020
Est. Valuation
$288.18M
Total Funding Raised
$102.35M
Company Overview
Xiamen LP Pharmaceutical Co., Ltd. operates in Healthcare & Life Sciences and is based in Xiamen. Its latest recorded funding round was a Series C round in August 2020.
Xiamen LP Pharmaceutical Co., Ltd. is a pharmaceutical company that develops and manufactures innovative clinical drugs and advanced drug delivery systems for various therapeutic areas.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xiamen LP Pharmaceutical Co., Ltd. Comparables
Compare Xiamen LP Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jinan Qinmu Fine Chemical Co., Ltd. | 82% | |
| Sandoo Pharmaceuticals and Chemicals Co., Ltd. | 81% | |
| Suzhou Lixin Pharmaceutical Co., Ltd. | 79% |
For institutional investors. Book with your work email.
Xiamen LP Pharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 19, 2020 | ||||
| Series B | Dec 19, 2017 | ||||
| Series A | Aug 1, 2015 |
For institutional investors. Book with your work email.
Xiamen LP Pharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hankang Capital | Series A |
| DYEE Capital | Series C |
| Qiandao Fund | Series C |
| SDIC Innovation Investment Management | Series B |
| HongShan Capital Group (HSG) | Series C |
| Industrial Bank Co., Ltd. | Series C |
| Shenzhen Capital Group | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 2753% MoM.
- Jan 25, 2025
Monthly visitors grew 144% MoM, reaching 1.7K.
For institutional investors. Book with your work email.
Xiamen LP Pharmaceutical Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Xiamen LP Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.
Is Xiamen LP Pharmaceutical Co., Ltd. a public or private company?
Xiamen LP Pharmaceutical Co., Ltd. is a private company.
What is the current stock price of Xiamen LP Pharmaceutical Co., Ltd.?
Xiamen LP Pharmaceutical Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Xiamen LP Pharmaceutical Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xiamen LP Pharmaceutical Co., Ltd. worth (valuation)?
Xiamen LP Pharmaceutical Co., Ltd.'s valuation is estimated at $288.2M based on funding round data.
Can I buy Xiamen LP Pharmaceutical Co., Ltd. stock?
Xiamen LP Pharmaceutical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xiamen LP Pharmaceutical Co., Ltd.'s last funding round?
Xiamen LP Pharmaceutical Co., Ltd.'s most recent funding round was Series C on August 19, 2020.
Who are the main investors in Xiamen LP Pharmaceutical Co., Ltd.?
Key investors in Xiamen LP Pharmaceutical Co., Ltd. include Hankang Capital, SDIC Innovation Investment Management, HongShan Capital Group (HSG).
Will Xiamen LP Pharmaceutical Co., Ltd. IPO soon?
No public IPO plans have been announced for Xiamen LP Pharmaceutical Co., Ltd..
How can I track Xiamen LP Pharmaceutical Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Xiamen LP Pharmaceutical Co., Ltd.'s shares on secondary markets.